NO20005497D0 - Heterocykliske derivater som inhiberer faktor Xa - Google Patents

Heterocykliske derivater som inhiberer faktor Xa

Info

Publication number
NO20005497D0
NO20005497D0 NO20005497A NO20005497A NO20005497D0 NO 20005497 D0 NO20005497 D0 NO 20005497D0 NO 20005497 A NO20005497 A NO 20005497A NO 20005497 A NO20005497 A NO 20005497A NO 20005497 D0 NO20005497 D0 NO 20005497D0
Authority
NO
Norway
Prior art keywords
heterocyclic derivatives
inhibit factor
relates
antithrombotic
anticoagulant
Prior art date
Application number
NO20005497A
Other languages
English (en)
Other versions
NO20005497L (no
NO320893B1 (no
Inventor
Peter William Rodney Caulkett
Roger James
Stuart Eric Pearson
Anthony Michael Slater
Rolf Peter Walker
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9809351.1A external-priority patent/GB9809351D0/en
Priority claimed from GBGB9903337.5A external-priority patent/GB9903337D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20005497D0 publication Critical patent/NO20005497D0/no
Publication of NO20005497L publication Critical patent/NO20005497L/no
Publication of NO320893B1 publication Critical patent/NO320893B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20005497A 1998-05-02 2000-11-01 Heterocykliske derivater som inhiberer faktor Xa og anvendelse derav, samt farmasoytisk sammensetning. NO320893B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9809351.1A GB9809351D0 (en) 1998-05-02 1998-05-02 Heterocyclic derivatives
GBGB9903337.5A GB9903337D0 (en) 1999-02-16 1999-02-16 Heterocyclic derivatives
PCT/GB1999/001308 WO1999057113A1 (en) 1998-05-02 1999-04-27 Heterocyclic derivatives which inhibit factor xa

Publications (3)

Publication Number Publication Date
NO20005497D0 true NO20005497D0 (no) 2000-11-01
NO20005497L NO20005497L (no) 2000-12-21
NO320893B1 NO320893B1 (no) 2006-02-06

Family

ID=26313572

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005497A NO320893B1 (no) 1998-05-02 2000-11-01 Heterocykliske derivater som inhiberer faktor Xa og anvendelse derav, samt farmasoytisk sammensetning.

Country Status (22)

Country Link
US (2) US6753331B1 (no)
EP (2) EP1528061A1 (no)
JP (1) JP2002513790A (no)
KR (1) KR20010043246A (no)
CN (1) CN1133634C (no)
AT (1) ATE282610T1 (no)
AU (1) AU754453B2 (no)
BR (1) BR9910179A (no)
CA (1) CA2331042A1 (no)
DE (1) DE69921994T2 (no)
EE (1) EE200000527A (no)
ES (1) ES2232131T3 (no)
HU (1) HUP0101712A3 (no)
IL (1) IL139406A (no)
NO (1) NO320893B1 (no)
NZ (1) NZ507835A (no)
PL (1) PL343706A1 (no)
PT (1) PT1082321E (no)
SI (1) SI1082321T1 (no)
SK (1) SK16512000A3 (no)
TR (1) TR200003200T2 (no)
WO (1) WO1999057113A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
GB9902989D0 (en) * 1999-02-11 1999-03-31 Zeneca Ltd Heterocyclic derivatives
GB9914342D0 (en) * 1999-06-19 1999-08-18 Zeneca Ltd Compound
GB9917344D0 (en) * 1999-07-24 1999-09-22 Zeneca Ltd Novel salt
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
GB0012448D0 (en) 2000-05-24 2000-07-12 Astrazeneca Ab New process
CN100408099C (zh) * 2000-11-09 2008-08-06 阿斯特拉曾尼卡有限公司 含有嵌段共聚物的口服药物组合物
GB0104752D0 (en) * 2001-02-27 2001-04-18 Astrazeneca Ab Pharmaceutical compositions
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
EP1569912B1 (en) 2002-12-03 2015-04-29 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
WO2004108671A1 (en) * 2003-06-06 2004-12-16 Suven Life Sciences Limited Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
WO2005012293A1 (ja) * 2003-08-01 2005-02-10 Nippon Soda Co., Ltd. フェニルアゾール化合物、製造法および抗酸化薬
SE0400014D0 (sv) * 2004-01-08 2004-01-08 Astrazeneca Ab Heterocyclic derivatives
WO2007008145A1 (en) * 2005-07-08 2007-01-18 Astrazeneca Ab Heterocyclic sulfonamide derivatives as inhibitors of factor xa
WO2007008144A1 (en) * 2005-07-08 2007-01-18 Astrazeneca Ab Heterocyclic sulfonamide derivatives as inhibitors of factor xa
US20080214495A1 (en) * 2005-07-08 2008-09-04 Astrazeneca Ab Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa
US20080221063A1 (en) * 2005-07-08 2008-09-11 Astrazeneca Ab Heterocyclic Sulfonamide Derivatives As Inhibitors Of Factor Xa
MD3762368T2 (ro) 2018-03-08 2022-07-31 Incyte Corp Compuși diol aminopirazină ca inhibitori ai PI3K-Y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
BR112021026410A2 (pt) 2019-07-01 2022-02-08 Tonix Pharma Ltd Anticorpos anti-cd154 e usos dos mesmos
JP2024503625A (ja) 2021-01-06 2024-01-26 トニックス ファーマ リミテッド 改変された抗cd154抗体により免疫寛容を誘導する方法
WO2025248134A1 (en) 2024-05-31 2025-12-04 Tonix Pharma Limited Treatment methods comprising administration of modified cd154 antibodies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115420A0 (en) * 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
AU1335897A (en) * 1995-12-21 1997-07-17 Du Pont Merck Pharmaceutical Company, The Isoxazoline, isothiazoline and pyrazoline factor xa inhibitors
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
GB9602294D0 (en) 1996-02-05 1996-04-03 Zeneca Ltd Heterocyclic compounds
UA56197C2 (uk) * 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
WO1998054164A1 (en) * 1997-05-30 1998-12-03 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
GB9715894D0 (en) * 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic derivatives
DE19743435A1 (de) * 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate

Also Published As

Publication number Publication date
ATE282610T1 (de) 2004-12-15
JP2002513790A (ja) 2002-05-14
IL139406A0 (en) 2001-11-25
ES2232131T3 (es) 2005-05-16
CN1308631A (zh) 2001-08-15
HUP0101712A3 (en) 2003-01-28
CN1133634C (zh) 2004-01-07
SK16512000A3 (sk) 2001-05-10
IL139406A (en) 2004-07-25
US6753331B1 (en) 2004-06-22
CA2331042A1 (en) 1999-11-11
DE69921994D1 (de) 2004-12-23
HK1034711A1 (en) 2001-11-02
NZ507835A (en) 2003-01-31
SI1082321T1 (en) 2005-06-30
BR9910179A (pt) 2001-01-09
TR200003200T2 (tr) 2001-02-21
AU754453B2 (en) 2002-11-14
NO20005497L (no) 2000-12-21
EP1082321A1 (en) 2001-03-14
AU3620699A (en) 1999-11-23
EE200000527A (et) 2002-02-15
EP1082321B1 (en) 2004-11-17
US20040266759A1 (en) 2004-12-30
PL343706A1 (en) 2001-08-27
PT1082321E (pt) 2005-03-31
NO320893B1 (no) 2006-02-06
HUP0101712A2 (hu) 2001-11-28
DE69921994T2 (de) 2005-12-01
WO1999057113A1 (en) 1999-11-11
EP1528061A1 (en) 2005-05-04
KR20010043246A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
DK1000033T3 (da) Heterocykliske derivater, som inhiberer Faktor Xa
NO20005497L (no) Heterocykliske derivater som inhiberer faktor Xa
MY124122A (en) Heterocyclic derivatives
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
MY139102A (en) Substituted n-aryl heterocycles, process for their preparation and their use as medicaments
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
AU3620799A (en) Heterocyclic derivatives which inhibit factor xa
DE59909607D1 (de) Tan-1057 derivate
NO20040821L (no) 3-substituerte 6,7-dihydroksytetrahydroisokinolinderivater for andvendelse som antibakterielle midler.
NO20013921D0 (no) Heterosykliske derivater som inhibitorer av faktor XA